Pelthos Therapeutics, Inc. (PTHS)
22.74
-1.64
(-6.73%)
USD |
NYAM |
Apr 07, 16:00
22.77
+0.03
(+0.13%)
After-Hours: 20:00
Pelthos Therapeutics Shareholders Equity (Quarterly) : 38.88M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 34.06M |
| Ligand Pharmaceuticals, Inc. | 1.017B |
| InspireMD, Inc. | 55.20M |
| CytomX Therapeutics, Inc. | 99.01M |
| Cibus, Inc. | 21.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.40M |
| Total Liabilities (Quarterly) | 91.52M |
| Debt to Equity Ratio | 0.8958 |
| Current Ratio | 2.027 |
| Net Debt Paydown Yield | -32.51% |